News

New study finds that fruit flies could be a model organism for learning the genetic pathways that affect human brain injuries and recovery.

St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a chemotherapy agent for treatment of ependymoma.

The deal is valued at up to €18 million and did not involve transfer of any employees.

MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.

Innovative monitoring system detects risk of infections up to 24 hours before symptoms appear.

Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable – including those affecting the brain, as well as autoimmune diseases and cancers.

The Genome Analysis Centre (TGAC) partners with Global HPC hardware giant SGI to address the most complex problems in genomics analysis.

UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.

Mass. General-developed compact system could shorten diagnostic time from days to hours, bring testing to point of care.

Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.